::

Ella E K Swaney1, Stephen Hearps2, Paul Monagle3

  • 1Haematology Group, Murdoch Children's Research Institute, 50 Flemington Road, Parkville, Melbourne 3052, Australia; Department of Paediatrics, University of Melbourne, Melbourne 3050, Australia.

Journal of proteomics
|February 7, 2024
PubMed
概括

临床有用的蛋白质选择 (CUSP) 协议通过优先考虑临床适用性来增强蛋白质标记物的发展. 这确保了新的疾病标志物可以很容易地转化为实际的医疗保健环境.